Long Noncoding RNAs: Clarity or Confusion?
Because They Are Such Elusive Prey, lncRNAs Have Yet to Emerge as Therapeutic Targets
Markets Expand for Single-Use Bioreactors
Biobags Offer Advantages Over Fixed-Tank Systems
The Challenges of Harmonizing Biomarker Data
Why Trial Success Depends on It
Top 10 Wall Street Losers of 2016
These Companies Lost the Most in a Down Year for Biopharma Stocks
For full access to this article login to GEN Select now.
ADMET Issues Slow Discovery
Assays, Computer Models, and Databases Improve Prediction of Drug Safety
- Speakers at Select Biosciences “Virtual Discovery Europe” conference held in London in late October discussed some of the key questions and challenges of the ADMET field. Pharma is struggling right now with the fact that the drug pipeline paradigm continues to shift. Finding safe drugs faster and earlier runs ...
Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.
Get GEN Select Access Now
- Do not put any letters or characters here if you are not a spy program.